This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perron, M. J.
Right arrow Articles by Sodroski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perron, M. J.
Right arrow Articles by Sodroski, J.

 Previous Article  |  Next Article 

Journal of Virology, March 2007, p. 2138-2148, Vol. 81, No. 5
0022-538X/07/$08.00+0     doi:10.1128/JVI.02318-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

The Human TRIM5{alpha} Restriction Factor Mediates Accelerated Uncoating of the N-Tropic Murine Leukemia Virus Capsid{triangledown}

Michel J. Perron,1 Matthew Stremlau,1 Mark Lee,1 Hassan Javanbakht,1 Byeongwoon Song,1 and Joseph Sodroski1,2*

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115,1 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 021152

Received 23 October 2006/ Accepted 20 November 2006

The host cell factors TRIM5{alpha}hu and Fv-1 restrict N-tropic murine leukemia virus (N-MLV) infection at an early postentry step before or after reverse transcription, respectively. Interestingly, the identity of residue 110 of the MLV capsid determines susceptibility to both TRIM5{alpha}hu and Fv-1. In this study, we investigate the fate of the MLV capsid in cells expressing either the TRIM5{alpha}hu or Fv-1 restriction factor. The expression of TRIM5{alpha}hu, but not Fv-1, specifically promoted the premature conversion of particulate N-MLV capsids within infected cells to soluble capsid proteins. The TRIM5{alpha}hu-mediated disassembly of particulate N-MLV capsids was dependent upon residue 110 of the viral capsid. Furthermore, the deletion or disruption of TRIM5{alpha}hu domains necessary for potent N-MLV restriction completely abrogated the disappearance of particulate N-MLV capsids observed with wild-type TRIM5{alpha}hu. These results suggest that premature disassembly of the viral capsid contributes to the restriction of N-MLV infection by TRIM5{alpha}hu, but not by Fv-1.


* Corresponding author. Mailing address: Dana-Farber Cancer Institute, 44 Binney Street, JFB 824, Boston, MA 02115. Phone: (617) 632-3371. Fax: (617) 632-4338. E-mail: joseph_sodroski{at}dfci.harvard.edu.

{triangledown} Published ahead of print on 29 November 2006.


Journal of Virology, March 2007, p. 2138-2148, Vol. 81, No. 5
0022-538X/07/$08.00+0     doi:10.1128/JVI.02318-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Sebastian, S., Grutter, C., de Castillia, C. S., Pertel, T., Olivari, S., Grutter, M. G., Luban, J. (2009). An Invariant Surface Patch on the TRIM5{alpha} PRYSPRY Domain Is Required for Retroviral Restriction but Dispensable for Capsid Binding. J. Virol. 83: 3365-3373 [Abstract] [Full Text]  
  • Langelier, C. R., Sandrin, V., Eckert, D. M., Christensen, D. E., Chandrasekaran, V., Alam, S. L., Aiken, C., Olsen, J. C., Kar, A. K., Sodroski, J. G., Sundquist, W. I. (2008). Biochemical Characterization of a Recombinant TRIM5{alpha} Protein That Restricts Human Immunodeficiency Virus Type 1 Replication. J. Virol. 82: 11682-11694 [Abstract] [Full Text]  
  • Kar, A. K., Diaz-Griffero, F., Li, Y., Li, X., Sodroski, J. (2008). Biochemical and Biophysical Characterization of a Chimeric TRIM21-TRIM5{alpha} Protein. J. Virol. 82: 11669-11681 [Abstract] [Full Text]  
  • Li, X., Sodroski, J. (2008). The TRIM5{alpha} B-Box 2 Domain Promotes Cooperative Binding to the Retroviral Capsid by Mediating Higher-Order Self-Association. J. Virol. 82: 11495-11502 [Abstract] [Full Text]  
  • Galla, M., Schambach, A., Towers, G. J., Baum, C. (2008). Cellular Restriction of Retrovirus Particle-Mediated mRNA Transfer. J. Virol. 82: 3069-3077 [Abstract] [Full Text]  
  • Wilson, S. J., Webb, B. L. J., Ylinen, L. M. J., Verschoor, E., Heeney, J. L., Towers, G. J. (2008). From the Cover: Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. USA 105: 3557-3562 [Abstract] [Full Text]  
  • Goldschmidt, V., Ciuffi, A., Ortiz, M., Brawand, D., Munoz, M., Kaessmann, H., Telenti, A. (2008). Antiretroviral Activity of Ancestral TRIM5{alpha}. J. Virol. 82: 2089-2096 [Abstract] [Full Text]  
  • Schaller, T., Hue, S., Towers, G. J. (2007). An Active TRIM5 Protein in Rabbits Indicates a Common Antiviral Ancestor for Mammalian TRIM5 Proteins. J. Virol. 81: 11713-11721 [Abstract] [Full Text]  
  • Arnaud, F., Murcia, P. R., Palmarini, M. (2007). Mechanisms of Late Restriction Induced by an Endogenous Retrovirus. J. Virol. 81: 11441-11451 [Abstract] [Full Text]  
  • Diaz-Griffero, F., Kar, A., Perron, M., Xiang, S.-H., Javanbakht, H., Li, X., Sodroski, J. (2007). Modulation of Retroviral Restriction and Proteasome Inhibitor-Resistant Turnover by Changes in the TRIM5{alpha} B-Box 2 Domain. J. Virol. 81: 10362-10378 [Abstract] [Full Text]  
  • Schaller, T., Ylinen, L. M. J., Webb, B. L. J., Singh, S., Towers, G. J. (2007). Fusion of Cyclophilin A to Fv1 Enables Cyclosporine-Sensitive Restriction of Human and Feline Immunodeficiency Viruses. J. Virol. 81: 10055-10063 [Abstract] [Full Text]